Pharmacological Monotherapy for Depressive Disorders: Current and Future—A Narrative Review
<i>Objective</i>: To narratively review currently available antidepressants and future potential antidepressants as monotherapy for the treatment of depressive disorders. <i>Methods</i>: Selective serotonin reuptake inhibitors (SSRIs), serotonin norepinephrine reuptake inhibi...
Saved in:
| Main Authors: | Keming Gao, Evrim Bayrak Oruc, Buket Koparal |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-03-01
|
| Series: | Medicina |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1648-9144/61/4/558 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Study of outcome of major depressive disorder treatment as per evidence based treatment protocol devised by department of psychiatry
by: R S Rawat, et al.
Published: (2015-07-01) -
Adverse Effects and Safety of Antidepressants and Psychedelics for Depression in Cancer: A Systematic Review of Randomized Controlled Trials
by: Renan Massanobu Maekawa, et al.
Published: (2025-03-01) -
Efficacy and safety of lemborexant in subjects with insomnia disorder receiving medications for depression or anxiety symptoms
by: Andrew Krystal, et al.
Published: (2025-03-01) -
The pharmacological management of depression – Update 2017
by: Elzbieta Osuch, et al.
Published: (2017-03-01) -
Depression, antidepressant use, and breast cancer incidence in the Sister Study cohort
by: Mary V. Díaz-Santana, et al.
Published: (2025-05-01)